VAS
GPCR icon

Vestmark Advisory Solutions’s Structure Therapeutics GPCR Stock Holding History

Vestmark Advisory Solutions’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$363K Hold
7,534
– – ﹤0.01% 1137
2025
Q4 		$524K Buy
+7,534
New +$308K 0.01% 986

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vestmark Advisory Solutions's GPCR Position: Q1 2026 in Review

Vestmark Advisory Solutions held its Structure Therapeutics (GPCR) position steady in Q1 2026 at 7,534 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #1137.

Vestmark Advisory Solutions first reported a position in GPCR in Q4 2025 and has held it in 2 quarters since. The position peaked at $524K in Q4 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Vestmark Advisory Solutions held 7,534 shares of Structure Therapeutics worth $363K as of Q1 2026.
  • Vestmark Advisory Solutions left its Structure Therapeutics share count unchanged in Q1 2026.
  • Structure Therapeutics made up ﹤0.01% of Vestmark Advisory Solutions's portfolio in Q1 2026, its #1137 holding.
  • Vestmark Advisory Solutions first reported a position in Structure Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Vestmark Advisory Solutions's Structure Therapeutics position peaked at $524K in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q1 2026, filed 15 May 2026.